Abstract
Application Safety of Alteplase in the Treatment of Acute Cerebral Infarction
Nanning Second People’s Hospital of Neurology, Nanning 530031, China
Correspondence Address:
TONG LI, Nanning Second People’s Hospital of Neurology, Nanning 530031, China, E-mail: www.litong.163@163.com
This study focuses on clinical effect of alteplase in the treatment of acute cerebral infarction. 100 cases of patients with acute cerebral infarction admitted to our hospital during 2014-2015 were randomly selected as study objects and divided into groups according to different therapeutic methods, with 50 cases in the observation group and the control group respectively. The control group received conventional non thrombolytic therapy. On this basis, the observation group received thrombolytic therapy with alteplase. Efficacy of the two groups was compared. Clinical efficacy of the observation group was more significant than that of the control group, with adverse reaction rates lower than that of the control group. Application of alteplase in treatment of acute cerebral infarction is with significant efficacy and high safety.
